Moreover, our previous finding that beta-CGRP is specifically increased in COVID-19 patients suffering from diarrhea [10] conceptually concurs with the current results showing a decrease in beta-CGRP in patients developing constipation on mAb treatment and indicates a role of this isoform in the physiology of intestinal motility. This evidence concerns the gene CALCB and COVID-19.